Risk Indicators in Patients With Ventricular Fibrillation During Acute Myocardial Infarction

NCT00175942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2005-09-15

No results posted yet for this study

Summary

Sudden cardiac death is in most cases triggered by ischemia-related ventricular tachyarrhythmias and accounts for 50% of deaths from cardiovascular disease in developed countries. Chronic elevation of indicators of coagulation activation has been found in patients with coronary heart disease , but a role of coagulation activation and proinflammatory state as a potential risk factor for ventricular fibrillation (VF) during acute myocardial infarction has not been investigated.

Conditions

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Carl E. Dempfle, Prof.Dr. · University Hospital of Mannheim, University of Heidelberg

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00175942 on ClinicalTrials.gov